U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460284) titled 'A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants' on Feb. 27.
Brief Summary: This is an open-label, single-center, single-dose study.
Study Start Date: March 15
Study Type: INTERVENTIONAL
Condition:
Basic Science
Intervention:
DRUG: 14C-RAY1225
subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Published by HT Digital Content Services with permission from Health Daily Digest....